Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 4576 - 4600 of 5559 in total

IDN-7314

Investigational

Phosphocreatine

Phosphocreatine - or creatine phosphate - is the phosphorylated form of creatine. It is primarily found endogenously in the skeletal muscles of vertebrates where it serves a critical role as a rapidly acting energy buffer for muscle cell actions like contractions via its ability to regenerate adenosine triphosphate (ATP) from...
Nutraceutical

3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide

Experimental

1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol

Experimental

Spanlecortemlocel

Investigational

Threonic acid

Experimental

A166

A166 is an antibody-drug conjugate composed of a novel cytotoxic drug (Duo-5, anti-microtubule agent) site-specifically conjugated to an anti-HER2 antibody (trastuzumab) via a stable protease-cleavable valine citrulline linker.
Investigational

AD-114

Investigational

Phosphocysteamine

Investigational

Prifinium

Prifinium is an antimuscarinic agent with antispasmodic and antiemetic properties. It may be useful for the treatment of irritable bowel syndrome .
Experimental

Amatuximab

Amatuximab has been used in trials studying the treatment and basic science of Mesothelioma, Ovarian Cancer, Ovarian Neoplasms, Pancreatic Cancer, and Mesothelioma, Malignant, among others.
Investigational

Methionine sulfoximine

Experimental

Ontamalimab

Ontamalimab is under investigation in clinical trial NCT03627091 (Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)).
Investigational

Enapotamab vedotin

Enapotamab vedotin is under investigation in clinical trial NCT02988817 (Enapotamab Vedotin (Humax-axl-adc) Safety Study in Patients With Solid Tumors).
Investigational

Mirvetuximab

Investigational

JNJ-28312141

Investigational

Bepranemab

Bepranemab is a recombinant humanized Igg4P monoclonal antibody directed against human Tau.
Investigational

Ulenistamab

Investigational

Tolebrutinib

Investigational

Octamethylenediamine

Experimental

Ro 12-7310

Experimental

Imolamine

Imolamine is a compound with a molecular weight of 260.33 g/mol with the formula diethyl[2-{5-imino-3-phenyl-4,5-dihydro-1,2,3-oxadiazol,-4-yl)ethyl]amine. It is developed under the brand name Coremax by Novartis consumer health SA.
Investigational

Acetylleucine

Used for treating vestibular-related imbalance and vertigo.
Experimental

Caflanone

Investigational

YK-4-279

Investigational
Displaying drugs 4576 - 4600 of 5559 in total